Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients

Background: The global push for the use of hydroxychloroquine (HCQ) and chloroquine (CQ) against COVID-19 has resulted in an ongoing discussion about the effectivity and toxicity of these drugs. Recent studies report no effect of (H)CQ on 28-day mortality. We investigated the effect of HCQ and CQ in...

Descripció completa

Dades bibliogràfiques

Autors principals:	A.J.J. Lammers, R.M. Brohet, R.E.P. Theunissen, C. Koster, R. Rood, D.W.M. Verhagen, K. Brinkman, R.J. Hassing, A. Dofferhoff, R. el Moussaoui, G. Hermanides, J. Ellerbroek, N. Bokhizzou, H. Visser, M. van den Berge, H. Bax, D.F. Postma, P.H.P. Groeneveld
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2020-12-01
Col·lecció:	International Journal of Infectious Diseases
Matèries:	COVID-19 Hydroxychloroquine Chloroquine Azithromycin Clinical course
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1201971220321755
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!